Data Analysis

Data Analysis

At T Cell Diagnostics, we go beyond generating raw data. Our advanced analytical services integrate cutting-edge immunological assays with robust data interpretation to transform complex immune readouts into clear, actionable insights.

By bridging laboratory findings with clinical relevance, we empower researchers and clinicians to make more informed decisions in clinical trials, therapeutic monitoring, and vaccine development.

Functional Profiling of Antigen-specific cells

Integration of Immunological and Clinical Data

Monitoring of Vaccine-Induced T Cell Responses

Evaluation of Immunotherapy Efficacy

X

Functional Profiling of Antigen-Specific T Cells

Using our whole-blood cytokine release assays, we evaluate the functional capacity of virus- or tumour-specific T cells by stimulating them with defined peptide pools and measuring cytokine secretion (e.g., IFN-γ, IL-2, Granzyme B). This approach allows for:

Clinical applicability, including point-of-care testing

This method has proven valuable in immunotherapy monitoring, such as tracking engineered TCR-T cells in patients with HBV-related liver cancer.

X

Integration of Immunological & Clinical Data

We combine immune profiling data with key clinical parameters—such as viral load, ALT/AST levels, and histological findings—to provide a comprehensive view of a patient’s immune status. This integrated approach enables:

Deeper insight into host-pathogen dynamics

By bridging immunology and clinical medicine, we support data-driven decision-making in patient care and trial design.

X

Monitoring of Vaccine-Induced T Cell Responses

T Cell Diagnostics offers quantitative and qualitative analysis of vaccine-elicited T cell responses. By measuring cytokine output following stimulation with vaccine antigens, we assess:

Immune performance in high-risk or immunocompromised populations

This service is beneficial in vaccine development programs and post-vaccination surveillance studies.

X

Evaluation of Immunotherapy Efficacy

Our longitudinal immune monitoring solutions enable precise tracking of T cell functionality post-treatment. For patients receiving adoptive T cell therapies or immune modulators, we provide:

Evidence to guide therapy adjustments or retreatment schedules

This capability is essential for evaluating the durability and effectiveness of cell-based immunotherapies.